Denali Therapeutics Reports First Quarter 2024 Financial Results and Business Highlights

Go back to Denali Therapeutics Reports First Quarter 2024 Financial Results and Business Highlights
(NASDAQ: DNLI) Delayed: 18.41 -0.25 (1.34%)
Previous Close $18.66    52 Week High $ 
Open $18.49    52 Week Low $ 
Day High $18.50    P/E N/A 
Day Low $18.01    EPS $ 
Volume 1,005,557